CaridianBCT, ex Gambro BCT, is a world leader in automated collections, therapeutic apheresis and cell therapy, as well as an industry leader within blood component separation and purification technologies.

CaridianBCT provides technology, products and services to blood centers, hospitals, and scientific, clinical and biotech researches.

Products include leading patented automated blood collection and separation systems, apheresis machines and cell processors.

In 2011, EQT IV signed an agreement to sell CaridianBCT to the Japanese medical technology company Terumo Corporation.